Defects in mitochondrial oxidative phosphorylation complexes, altered bioenergetics and metabolic shift are often seen in cancers. Here we show a role for the dysfunction of the electron transport chain component cytochrome c oxidase (CcO) in cancer progression. We show that genetic silencing of the CcO complex by shRNA expression and loss of CcO activity in multiple cell types from the mouse and human sources resulted in metabolic shift to glycolysis, loss of anchorage-dependent growth and acquired invasive phenotypes. Disruption of the CcO complex caused loss of transmembrane potential and induction of Ca2+/Calcineurinmediated retrograde signaling. Propagation of this signaling includes activation of PI3-kinase, IGF1R and Akt, Ca2 + -sensitive transcription factors and also TGFβ1, MMP16 and periostin, which are involved in oncogenic progression. Whole-genome expression analysis showed the upregulation of genes involved in cell signaling, extracellular matrix interactions, cell morphogenesis, cell motility and migration. The transcription profiles reveal extensive similarity to retrograde signaling initiated by partial mitochondrial DNA depletion, although distinct differences are observed in signaling induced by CcO dysfunction. The possible CcO dysfunction as a biomarker for cancer progression was supported by data showing that esophageal tumors from human patients show reduced CcO subunits IVi1 and Vb in regions that were previously shown to be the hypoxic core of the tumors. Our results show that mitochondrial electron transport chain defect initiates a retrograde signaling. These results suggest that a defect in the CcO complex can potentially induce tumor progression.
INTRODUCTION
In keeping with the Warburg hypothesis, proposing aerobic glycolysis as an important factor in tumor growth, 1 altered mitochondrial function and increased utilization of glucose for energy are hallmarks of many proliferating tumors. A number of studies have shown defective mitochondrial electron transport chain complexes (ETC) in human cancers. [2] [3] [4] [5] [6] Epidemiological studies have proposed defective complex I as a biomarker for aggressive thyroid, breast, colon and other cancers. 7 Similarly, mutations in Complex III and complex IV (cytochrome c oxidase (CcO)) have been reported in multiple cancers. 3, 5, 6 In a majority of these cases, point mutations and deletions in mitochondrial DNA (mtDNA) were shown to be the cause of the defective assembly/ function of ETC complexes. However, it still remains unclear whether the process of tumorigenesis could be attributed to defects in the ETC complexes.
Loss of mtDNA copy number has been reported in breast, prostate, hepatocellular and lung cancers, and we have shown that partial mtDNA depletion mediates tumorigenesis by activating a Ca 2+ -Calcineurin (Cn)-dependent retrograde signaling. 8, 9 The onset of this signaling is characterized by loss of mitochondrial membrane potential (ΔΨm). This results in sustained elevation of [Ca 2+ ] c followed by activation of Cn, a Ca 2+ -dependent phosphatase resulting in the activation of a set of stress-responsive transcription factors: NFκB (p50:cRel), NFAT, CREB and C/EBPδ. 9 This signaling also activates an RNA-binding protein, hnRNPA2, which acts as a transcription coactivator by binding to the enhanceosome complex through protein-protein interaction. 10, 11 The stress signaling induces the expression of a wide array of genes with roles in metabolic shift from oxidative phosphorylation to glycolysis, invasiveness, morphological changes and resistance to apoptosis. 8, 12 Lowering of mtDNA copy number induces stress signaling pathway, which reprograms cells to a highly proliferative and tumor-producing phenotype and also induces EMT in some epithelial cells. 13 CcO is a bigenomic enzyme with three of the 13 subunits encoded by mtDNA and remaining 10 subunits encoded by nuclear genes. The nuclear subunits are thought to be important for the assembly or regulation of enzyme activity. Our studies and others' showed that siRNA-mediated depletion of the peripheral subunits IVi1, Vb and VI not only affects the assembly of intact complex but also the CcO activity, culminating in respiratory dysfunction and disruption of ΔΨm. 14, 15 In addition, subunits IVi1 and Vb levels are selectively reduced in hypoxia, myocardial ischemia, alcohol toxicity and other disease conditions. [16] [17] [18] [19] [20] Loss of CcO complex also disrupted respirosome super complexes that are thought to have an important role in the regulation of electron transport, OXPHOS and attenuation of reactive oxygen species production. [21] [22] [23] Here we show that silencing of subunits IVi1 or Vb of CcO induces a mitochondrial retrograde signaling, which largely mimics the signaling that we reported in mtDNA-depleted cells. 13 The cells acquired invasiveness and showed loss of contact inhibition generally observed in tumor cells. There was increased expression of marker genes of the Ca 2+ /Cn signaling pathway. Figure 1a ). C2C12 cells expressing a scrambled shRNA are referred to as control cells. In C2C12 cells, silencing of neither of these subunits had an effect on mRNA levels for other subunits of ETC complexes (Supplementary Fig S1A) . In addition, the level of complex IV (CcO) (Figure 1c) , as tested by the Blue Native PAGE, was markedly reduced in both CcO4KD and CcO5bKD cells, although the levels of complexes I, II and V did not change. To visualize the effects of CcO knockdown on the organization of the respiratory super complexes, we separated digitonin-solubilized mitochondrial extracts on 5-10% gradient blue native gel and probed with antibodies to subunits of either complex I or IV. As seen in Figure 1d , left panel, the slow migrating super complexes containing CcO were significantly depleted in CcOKD cells. On the other hand, when probed with antibody to complex I subunit Grim19 (Figure 1d , right panel), the larger super complexes were absent or reduced in CcOKD cells, whereas smaller complexes that likely do not contain CcO were unaffected. The CcO enzyme activity was significantly reduced in the knockdown cells and was consistent with mRNA levels in both CcO4KD and CcO5bKD cells (Figure 1e ). Activities of complex I were marginally lower in CcO4KD cells, and complex III activity remained nearly the same in these cells (Figure 1e ). Figure 2a shows the effects of CcO subunit knockdown on mitochondrial morphology. Mitochondria in CcO4KD cells appeared as small fragments and many formed ring-like structures with loss of filamentous network (Figure 2a, right panel) . Such donut-shaped mitochondrial structures have been reported in cells subjected to hypoxia or exposed to mitochondrial toxins. 24 Mitochondrial network was also affected in CcO5bKD cells, although to a lesser extent compared with CcO4KD cells (Figure 2a , bottom left). To ascertain that the altered mitochondrial morphology was because of loss of CcO activity, we reconstituted cells by ectopic expression of shRNA-resistant subunit IVi1 (CcO4KDshRC4). As shown in Figure 2b , CcO holoenzyme was reconstituted in these cells and the enzyme activity was restored to nearly 80% of control cells (Figure 2c Bioenergetic stress and metabolic shift in cells with disrupted CcO complex Oxygen consumption rates (OCR) in control, CcO4KD and CcO5bKD cells were measured using an XF24 flux analyzer (Figure 3a , left panel). As expected, the basal OCR was lower in both CcO4KD and CcO5bKD cells compared with the control, whereas in CcO4KDshRC4 cells basal respiration was higher than the parental CcO4KD cells (Figure 3b) . The ATP-coupled respiration (measured after adding oligomycin) and maximum respiratory capacity (measured after the addition of uncoupler, 2,4 dinitrophenol) ( Figure 3c ) were markedly reduced in CcO4KD and CcO5bKD cells. In CcO4KDshRC4 cells, both ATP-coupled respiration and maximum respiratory capacity were significantly recovered compared with CcO4KD cells. Extracellular acidification rate (ECAR) is a measure of glycolytic flux and is significantly higher in CcO4KD cells compared with control cells (Figure 3a, right panel) . In the CcO4KDshRC4 cell line, the ECAR levels are closer to control levels. Interestingly, in CcO5bKD cells, basal ECAR levels were similar to control cells. However, although the addition of oligomycin resulted in a significant increase in ECAR in control cells, the effect was comparatively modest in CcO5bKD cells, suggesting that in CcO5bKD cells basal glycolytic flux is closer to its maximum capacity compared with control cells (Figure 3a As seen in Figure 4a , cellular ATP levels were 15-20% lower in the knockdown cells. However, less than 10% ATP synthesized in CcO4KD and CcO5bKD cells were resistant to oligomycin treatment, whereas it was~30% in control cells. In CcO4KDshRC4 cells, both total cellular ATP and oligomycin-resistant ATP levels were recovered compared with CcO4KD cells (Figure 4a ). These results suggest a switch to glycolysis as the main source of ATP in CcOKD cells.
The switch to glycolysis was further supported by results in Figure 4b showing an approximately two-fold increase in were incubated with 1 μM DCFHDA at 37°C for 20 min. For catalase treatment, 1U of Polyethylene glycol-conjugated Catalase was added 10 min before DCFHDA addition, as described in Materials and methods available online in Supplemental information. H 2 O 2 (2.5 mM) was used as a positive control. *P ⩽ 0.05; **P ⩽ 0.01; n = 3. glycolytic enzyme, hexokinase and phosphofructokinase (PFK) in CcO4KD cells. In CcO5bKD cells, the increase in hexokinase and phosphofructokinase activities was about 20-45% over the control. In agreement with these data, glucose uptake in both of these cell lines was more than twofold higher than control cells (Figure 4c ). Wortmannin is an inhibitor of PI3-Kinase, whereas FK506 is an inhibitor of Cn. BAPTA-AM is a Ca 2+ chelator. All three compounds significantly inhibited glucose uptake by both CcO4KD and CcO5bKD cells. CcO4KDshRC4 cells showed significantly lower glucose uptake than CcO4KD cells. BAPTA-AM reduced glucose uptake further in these cells, whereas Wortmannin and FK506 had only marginal effect (Figure 4c) . Glucose uptake was supported by about a twofold increase in Glut4 mRNA levels in both CcOKD cells (Figure 4d ). Interestingly, Glut1 levels were largely unaffected in both knockdown cells. These results together show that disruption of CcO activity causes a metabolic adaptation to increased glycolysis for ATP production.
Activation of retrograde signaling in CcO-disrupted cells Mitochondrial stress induced by depletion of mtDNA in C2C12 cells was shown to activate a distinctive Ca 2+ /Cn stress signaling, which induced the expression of many nuclear genes including those involved in tumor progression. [8] [9] [10] Increased Cn activity is an indicator of mtDNA depletion-induced Mt-RS. 8, [25] [26] [27] Cn mRNA levels were induced by twofold to threefold in both CcO4KD and CcO5bKD cells, suggesting the activation of the Cn pathway ( Figure 5a) . The Cn mRNA level was markedly reduced in CcO4KDshRC4 cells, indicating that the altered Cn expression was because of the dysfunctional CcO complex. We observed increased expression of nuclear oncogenes TGFβ and IGF1R in CcO4KD cells (Figure 5a ), whereas the levels were reduced in CcO4KDshRC4 cells. IGF1R was not induced in CcO5bKD cells, suggesting a subtle difference in the signaling between the CcO4KD and CcO5bKD cells. These results collectively indicate that CcO disruption induces Cn activation and induced expression of several key markers of Mt-RS. To determine the role of Ca 2+ /Cn in stress signaling mediated by CcO subunit knockdown, cells were treated with FK506, an inhibitor of Cn and BAPTA-AM, a Ca 2+ chelator. As shown in Figure 5b , both BAPTA-AM and FK506 significantly attenuated stress-induced expression of TGFβ, MMP16 and Glut4 genes in CcO4KD cells.
To gain insight on the magnitude of altered gene expression in response to CcO disruption, we performed a whole-genome microarray analysis of control and CcO4KD cells. More than 100 genes were upregulated and~35 genes were downregulated in CcO4KD cells compared with control C2C12 cells. We used a cutoff of fourfold changes in our analysis (Figure 6a ). Functional cluster analysis showed an increase in genes involved in metabolism, cell morphogenesis, ion transport, cell motility and migration (Figure 6a) . Interestingly, many of these genes have been shown to have important roles in a wide variety of cancers and also that these same genes were shown to be induced in mtDNA-depleted C2C12 cells. 8, 12 The list of genes and changes in their expression levels has been presented in Supplementary Fig  S2A. A partial list of genes that are upregulated in response to CcO disruption has been presented in Figure 6b . Induced expression of some of the genes detected in microarray analysis was verified by real-time quantitative PCR (Figure 6c ). Many genes with recognized roles in tumor development such as TGFβ, MMP16, PDK4 and periostin were all upregulated in CcO4KD cells. Notably, the same genes were also upregulated in CcO5bKD cells, although at different levels (Figure 6c ). The causal role of CcO dysfunction in upregulation of these genes was evident by data in Supplementary Fig. S2B showing that the levels of expression of these stress target genes were markedly reduced in CcO4KDshR4 cells (Supplementary Figure S2B) . Importantly these cells showed functional CcO complex.
Phenotypic alterations and altered growth characteristics by CcO disruption The control C2C12 cells become confluent in 3 days, differentiate to myotubes and die after 3-4 days. CcO4KD cells, on the other hand, showed unusual growth characteristic in that they survive for nearly a week after becoming confluent and lose the ability to differentiate into myotubes (Supplementary Fig S3A) . CcO5bKD cells differentiate to myotubes, but at a much slower rate compared with control. Growth rate was measured by plating an equal number of cells and following the number of live cells for 3 days. Interestingly, both CcOKD cells grew at significantly slower rates compared with control cells (Supplementary Fig S3B) . Anchorage-independent growth is considered one of the important characteristics of malignantly transformed cells. Soft agar colony formation is a widely used readout for assessing anchorage-independent growth of tumor cells. Remarkably, both CcO4KD and CcO5bKD cells formed several distinct visible colonies on soft agar in about 3 weeks (Figure 7a ). The control cells formed fewer colonies under these growth conditions (Figure 7a) . Notably, colony formation with CcO4KD cells was markedly inhibited by PI3-kinase inhibitor, Wortmannin and IGF1R inhibitor Picropodophyllin, suggesting the requirement of the PI3-kinase/IGF1R pathway in mediating this phenotypic transformation (Figure 7b ). These results are consistent with our previous reports on Mt-RS induced by partial mtDNA depletion, which involves activation of PI3-K and induction of IGF1R expression. 28 The mitochondria targeted antioxidant Mito-CP, on the other hand did not have any significant effect, suggesting that the loss of contact inhibition in these cells may not be associated with mitochondrial reactive oxygen species (Figure 7a) . The quantification of colony numbers with and without treatments is presented in Figure 7b . Similarly, the number of colonies formed by CcO4KDshRC4 cells was significantly lower than CcO4KD cells (Figure 7a, bottom panel) .
As 3D cultures mimic the in vivo tumor environment more closely, we grew these cells in growth factor-reduced Matrigel 3D cultures. Figure 7c shows representative colonies from multiple experiments. Phalloidin staining of both CcO4KD and CcO5bKD Figure 7c) showed that the cells formed large multicellular colonies (430 μm diameter) (right panel), which survived 43weeks, whereas control cells formed smaller colonies with fewer cells. Previously, we showed that Akt1, an oncogenic kinase, is activated through retrograde signaling in cells subjected to mtDNA depletion. 11 Immunofluorescence images in Figure 7c (bottom panel) show that Akt1 staining was significantly increased in colonies from both CcO knockdown cell lines. Skeletal myocytes transform into aggressive rhabdomyosarcomas in vivo. The tumorispheres formed by CcO4KD and CcO5bKD cells in 3D culture are consistent with the sarcomas, suggesting the in vivo tumorigenic potential of these CcOKD cells.
cells (
Invasion through the basement membrane is a hallmark of highly invasive malignant cells. The ability to invade a matrigelcoated membrane is tested using an in vitro assay indicative of the in vivo metastatic potential of the cells. Figure 7d shows that after 48 h of incubation almost no control cells migrated across the membrane, whereas CcO4KD and CcO5bKD cells migrated through the membrane, suggesting their invasive potential. Restoration of CcOIVi1 expression in CcO4KD cells reversed the invasive potential of cells (Figure 7d ). These results collectively show that disruption of CcO complex induces Mt-RS, which in turn induces changes in growth characteristics, cell morphology and invasive potential. To confirm the generality of this observation, we knocked down CcOIVi1 in multiple human cell lines including esophageal cancer, breast cancer and embryonic kidney cells. The reduction in CcOIVi1 levels in these cell lines varied from 50% to over 80% (Supplementary Fig S4A) . The ratio of extracellular acidification to O 2 consumption rates was significantly higher in knockdown cells compared with corresponding control cells, indicating increased glycolysis (Supplementary Fig S4B) . Matrigel invasion assay was carried out to determine the invasive potential of CcOKD cells. As seen in Supplementary figure S4C, cell lines with disrupted CcO level invaded the basement membrane to a greater extent than the corresponding control cells. The extent of invasion, however, varied between cell lines.
Solid tumors often contain severely hypoxic regions. 29 The relevance of CcO disruption in cellular transformation was assessed in the hypoxic regions of human esophageal tumors and mouse xenograft sections. As seen from Figure 8 , in serial sections, the levels of subunits IVi1 and Vb were significantly lower in the core of the tumor mass, which is generally considered as a more hypoxic region, compared with the periphery. Corresponding right panels show the relative diaminobenzidine staining, measured as indicated in methods. Supplementary Fig  S5A shows the regions used for measuring diaminobenzidine intensities. As seen in Figure 8 , levels of CcOIVi1 and Vb drop significantly toward the interior of the tumor mass compared with the periphery. SDHA, a mitochondrial protein unaffected by hypoxia, was distributed fairly evenly throughout the tumor (Supplementary Fig S5B) . Interestingly, similar pattern of differential CcOIVi1 staining with more prominent staining in the periphery of the tumor mass and significantly lighter staining in interior regions was observed in mouse xenografts of human esophageal squamous cell carcinoma (Supplementary Fig S5C, left  panel) . The region of lower CcOIVi1 staining corresponded with the region of the same mouse xenograft previously established as hypoxic by pimonidazole staining (Supplementary Fig S5C) . 30 There was no significant difference in the distribution of TOM20, a mitochondrial outer membrane protein not affected by hypoxia ( Supplementary Fig S5C, right panel) . These results suggest that the CcO subunit loss has a pathological relevance in tumor progression.
DISCUSSION
Mitochondria participate in a multitude of physiological functions including generation of ATP, regulation of Ca 2+ homeostasis, integration of metabolic pathways, biosynthesis of metabolites, steroid hormone and Urea biosynthesis, and integration and execution of apoptosis. Although these functions have been well established for many decades, recent studies suggest additional roles of mitochondria as sensors of environmental and cellular stresses. [31] [32] [33] Disruption of normal mitochondrial function by these stresses and resulting cellular alterations form the basis for a growing list of human diseases, such as mitochondrial myopathies, neurodegenerative diseases, diabetes and many age-related diseases. 34 Although reduced bioenergetic capacity is one of the common outcomes of mitochondrial dysfunction, the mitochondrial stress-induced signaling appears to have a role in a wide range of mitochondrial diseases. 27, [34] [35] [36] [37] The involvement of mitochondria in cancer was first suggested by Warburg who noted that cancer cells have damaged respiration and increased lactate production, a phenomenon referred to as 'aerobic glycolysis' or 'Warburg Effect'. 1 Since then, several studies have shown diminished mitochondrial respiration in a wide range of cancers, which appears to be a hallmark of many proliferating tumors. 38 The cause and effect relationship between aerobic glycolysis and tumorigenesis is a topic of intense investigation. Warburg also noted 'that injury to respiration should not be so great that the cells are killed, for then no cancer cells could result'. 1 This suggests that it is not mere depletion of ATP or loss of other essential functions of mitochondria that might have a role in cancer development. Instead, an interesting possibility is that signaling initiated by mitochondria under stress could have a role in carcinogenesis. 13, 39, 40 Mitochondrial function can be affected by both genetic and environmental factors. Defects in mtDNA such as mutations, deletions and reduction of copy number-all of which affect the mitochondrial ETC-have been reported in a wide variety of cancers. 3 Mutations in complex I subunit ND6 were shown to increase the metastatic potential by overproducing reactive oxygen species, whereas an ND5 mutation promoted tumorigenesis by oxidative stress and Akt activation. 41, 42 Similarly, mitochondrial dysfunction resulting from mutations in nuclear DNAencoded mitochondrial proteins, such as SDH, FH and IDH, are also strongly associated with specific cancers. [43] [44] [45] In these instances, secondary metabolites that accumulate because of the absence of the corresponding functional enzyme have been suggested to have a role in metabolic reprogramming of cancer cells. 34 A large number of studies have shown defective CI, CII and CIV in many human tumors and mouse xenografts. 34 Similarly, we and others have shown diminished CcO subunit levels and CcO activity under various pathologies including alcohol toxicity, myocardial disease, cancers, hypoxia and exposure to environmental toxins. 46 In the present study using multiple cell lines, we investigated the causative role of CcO dysfunction in metabolic reprogramming and tumor progression by shRNA-mediated knockdown of CcO subunits IVi1 and Vb. Our results strikingly show that reduced CcO function and reduced ΔΨm in C2C12 myoblasts induced a shift in metabolism toward glycolysis, and induced invasive and anchorage-independent growth characteristics, similar to tumor cells. Interestingly, CcOKD cells grow at a much slower rate compared with control cells, suggesting that the stress signaling has a more significant effect on the invasive potential rather than the proliferative phenotype of the cells. These results in effect largely recapitulate the 'Warburg effect'. Our observation that disruption of CcO activity induces a metabolic shift, and associated changes in nuclear gene expression profile and growth characteristics, has important significance in tumor progression. These are direct effects of CcO dysfunction, as reconstitution of activity by expressing the shRNA-resistant subunit significantly reversed the signaling cascade and restored the cell growth characteristics.
It is widely believed that Hif-1α, which is activated under hypoxia or by increased reactive oxygen species production, is mainly responsible for the adaptive metabolic shift to cope with the reduced O 2 availability. 47, 48 Under the present mitochondrial stress conditions, however, there was no detectable Hif-1α activation (data not shown). Furthermore, our previous studies have shown that the mitochondrial retrograde signaling mediated by the Ca 2+ /Cn pathway activates IGF1R, PI3-K/Akt1 and hnRNPA2, resulting in a metabolic shift, as well as transcriptional reprogramming of gene expression. In support of this observation, the metabolic shift and phenotypic changes were not affected by Mito-CP, a mitochondrial antioxidant, but inhibited by Cn inhibitor and also by PI3-K and IGF1R inhibitors, suggesting the role of the Ca 2+ /Cn pathway in these CcO-disrupted cells. Subunit IVi1 of CcO is a transmembrane protein that has been suggested to have a role in the enzyme assembly. Subunit Vb, on the other hand, is a peripheral protein associated with the complex on the matrix side. Surprisingly, knockdown of both subunits caused disruption and loss of activity, although to significantly different levels. Consistent with the less severe effect on CcO activity, most of the gene expression and phenotypic changes in CcO5bKD cells are much less severe compared with CcO4KD cells. However, expression of some of the marker genes did not conform to this rule. We envision two possibilities for this difference in the levels of induction of marker gene expression, invasive properties of cells and the extent of loss of contact inhibition. It is likely that either the threshold of signaling strength in these cells is different or, possibly, there is subtle difference in the nature of signaling. It has been shown earlier that some of the component subunits of the ETC including CcO Vb likely have other cytosolic functions. 49 These could potentially make the phenotypic outcomes more complex to interpret. Similarly, experiments with human cell lines showed that the effect of loss of cytochrome oxidase and resulting mitochondrial dysfunction depends significantly on the cell type and its metabolic phenotype. These possibilities will require further investigation.
MATERIALS AND METHODS

Cell lines and reagents
C2C12 murine skeletal myoblasts (ATCC CRL1772) and HEK 293 human embryonic kidney cells (ATCC CRL3216) were grown in Dulbecco's modified Eagle's medium (Life technologies, Grand Island, NY, USA) supplemented with 10% fetal bovine serum and 0.1% Penicillin/ Streptomycin. Human esophageal squamous cell carcinoma cell line TE11 was a gift from Dr Nishihira 51 who established that the cell line and cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (Sigma-Aldrich, St. Louis, MO, USA) and 1% penicillin/streptomycin (Life technologies), as described previously. 50 The earliest frozen stocks of TE11 have been stored at the Cell Culture Core of the University of Pennsylvania. We have propagated cells from frozen stocks of the original vials that were authenticated by short tandem repeat analysis for highly polymorphic microsatellites FES/FPS, vWA31, D22S417, D10S526 and D5S592, at the Cell Culture Core. These tests were done to validate the identity of cells by comparing cells at the earliest stocks we have and those grown for 48-12 passages. MCF7 human breast cancer cells (ATCC HTB22) were grown in Eagle's minimal essential medium supplemented with 10% fetal bovine serum, 10 μg/ml Insulin and 0.1% Penicillin/Streptomycin. All cell lines have been tested for mycoplasma contamination on a regular basis. Stable C2C12 cell lines expressing shRNA against subunit IVi1 or Vb were generated using pSilencer 2.0 vector, as described before.
14 Stable HEK 293 T, TE11 and MCF7 cell lines expressing shRNA against human subunit IVi1 were generated using the PLKO.1 lentiviral vector. Selected clones were maintained in a medium containing 1 mM pyruvate and 50 μg/ml uridine and analyzed for CcO IVi1 and CcO Vb levels by both RT-PCR and Immunoblotting. Primary antibodies used for immunostaining were from Abcam, Cambridge, MA, USA (CcOIVi1, #ab110272; CcO5b, #ab110263; MTCOI, #ab14705; ATPB, #ab14730; Grim19, #ab110240; SDHA, #ab14715) and SantaCruz Biotechnology, Dallas, TX, USA (Tom20, sc-11415). IR-conjugated secondary antibodies (IRdye 800, Cat # 926-32210 and IRdye 680, Cat # 926-68021) were from Licor Biotechnology, Lincoln, NE. Fluorescent secondary antibodies (AlexaFluor 488 and AlexaFluor 594) were from Life technologies, Grand island, New York, NY, USA. [52] [53] [54] [55] [56] [57] [58] Microarray analysis Total RNA from control and CcO IVi1-silenced cells was prepared using the RNeasy kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. Whole-genome expression analysis was carried out using Affymetrix GeneChip Mouse Gene 2.0 ST Array (Affymetrix, Santa Clara, CA, USA). The data were processed by Affymetrix Expression Console using Probeset-Summarize-Engine with default setting of RMA method to calculate the expression level for each probeset of the array (file: rmagene-full.summary.txt, 59 ). A list of genes (file: zgene_symbol_list.txt.2x0. 01p, 59 ) was then generated, using our own code in Matlab and C-shell script (code: myp.m and mycluster.csh, 59 ), with the criteria that the fold change is more than two and the P-value of one-tailed Welch's t-test is o0.01. The generated gene list was functionally annotated using the online bioinformatics resource, DAVID 6.7 (http://david.abcc. ncifcrf.gov/, 60 ) with default setting (file: myfa_table_all.txt.2x0.01p, 59 ). The functional groups of genes were extracted from the annotated file using the corresponding terms (for example, 'signal transduction') with our own C-shell script (file: myfa.csh,
59
). Data are deposited in GEO under acquisition number GSE68525.
Statistics
Data are presented as the mean ± s.d. using n = 3-5, as indicated in Supplementary Figures. Statistical analyses were performed using Microsoft Excel or Origin software. Differences were determined by unpaired two-tailed Student t-test and equality of variance was checked using F-test. A value of Po 0.05 was considered statistically significant.
